Literature DB >> 20378027

Clinical, serologic and instrumental data of ten patients affected by sclerodermatous chronic graft versus host disease: similarities and differences in respect to systemic sclerosis.

G Barausse1, P Caramaschi, C Scambi, F Benedetti, M Sorio, M Tinelli, I Tinazzi, L Benini, L M Bambara, D Biasi.   

Abstract

Chronic graft versus host disease (cGVHD), the most common late complication of allogeneic haematopoietic stem cell transplantation (HSCT), may present with sclerodermatous lesions resembling in some cases the cutaneous involvement of systemic sclerosis (SSc). Certain pathogenetic findings connect the two diseases. In this report we describe ten subjects affected by cGVHD who underwent the examinations routinely carried out to stage SSc patients. Demographic, clinical, serologic and instrumental data were recorded. These patients showed differences in appearance, extent and progression of the sclerodermatous lesions with greater involvement of the trunk and proximal part of the limbs than the extremities. In seven subjects ANA test was positive; scleroderma-associated autoantibodies were not detected in any of the cases. Moreover, typical organ involvement of SSc was not found. Only one patient developed Raynauds phenomenon after HSCT and only one patient demonstrated a nailfold videocapillaroscopic scleroderma pattern. Except for cutaneous involvement of cGVHD, that may resemble SSc, the clinical features of the two diseases are quite different, suggesting that the fibrotic process characterizing cGVHD and SSc has different etiologies and different initial pathobiologic events.

Entities:  

Mesh:

Year:  2010        PMID: 20378027     DOI: 10.1177/039463201002300139

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  5 in total

1.  Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease.

Authors:  Kathryn J Martires; Kristin Baird; Seth M Steinberg; Lana Grkovic; Galen O Joe; Kirsten M Williams; Sandra A Mitchell; Manuel Datiles; Fran T Hakim; Steven Z Pavletic; Edward W Cowen
Journal:  Blood       Date:  2011-07-26       Impact factor: 22.113

2.  Optical coherence tomography angiography of normal skin and inflammatory dermatologic conditions.

Authors:  Anthony J Deegan; Faezeh Talebi-Liasi; Shaozhen Song; Yuandong Li; Jingjiang Xu; Shaojie Men; Michi M Shinohara; Mary E Flowers; Stephanie J Lee; Ruikang K Wang
Journal:  Lasers Surg Med       Date:  2018-01-22       Impact factor: 4.025

Review 3.  Fibrotic and sclerotic manifestations of chronic graft-versus-host disease.

Authors:  Carrie L Kitko; Eric S White; Kristin Baird
Journal:  Biol Blood Marrow Transplant       Date:  2012-01       Impact factor: 5.742

4.  Risk factors for the development of systemic sclerosis: a systematic review of the literature.

Authors:  Samuel Abbot; David Bossingham; Susanna Proudman; Caroline de Costa; Albert Ho-Huynh
Journal:  Rheumatol Adv Pract       Date:  2018-10-11

5.  SFRP4 Expression Is Linked to Immune-Driven Fibrotic Conditions, Correlates with Skin and Lung Fibrosis in SSc and a Potential EMT Biomarker.

Authors:  Ilaria Tinazzi; Panji Mulipa; Chiara Colato; Giuseppina Abignano; Andrea Ballarin; Domenico Biasi; Paul Emery; Rebecca L Ross; Francesco Del Galdo
Journal:  J Clin Med       Date:  2021-12-13       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.